Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-24 @ 10:36 PM
NCT ID:
NCT00683735
Eligibility Criteria:
Inclusion Criteria:
* Type 2-diabetes mellitus
* BMI 25-35 kg/m2
* HbA1c 6.5%-9% (without OHA medication)
* HbA1c 6%-8.5% (OHA monotherapy with metformin or sulfonylurea)
* Patient understands the study-procedures
Exclusion Criteria:
* Type 1-diabetes mellitus
* C-peptide \< 0.7ng/mL (0.23 nmol/L)
* Patient has been taking oral anti-hyperglycemic agent (OHA) within the prior 12 weeks, except metformin or a sulfonylurea
* Patient has required insulin therapy within the past 12 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
75 Years
Study:
NCT00683735
Study Brief:
Protocol Section:
NCT00683735